Skip to main navigation

News & Resources
Contact

Science & Technology
Our Programs
About Us
Working At Eyepoint
Investors

Search this site

Investor Menu

Financial Information
News & Events
Corporate Governance
FAQs
Contact
- IR Contact
- Email Alerts

Science & Technology
Our Programs
About Us
Working At Eyepoint
Investors

News & Resources
Contact

Financial Information
News & Events
Corporate Governance
FAQs
Contact
- IR Contact
- Email Alerts

Earnings Releases

Show all

2025

Q4

EyePoint Reports Fourth Quarter and Full-Year 2025 Financial Results and Highlights Recent Corporate Developments

Q3

EyePoint Reports Third Quarter 2025 Financial Results and Highlights Recent Corporate Developments

Q2

EyePoint Reports Second Quarter 2025 Financial Results and Highlights Recent Corporate Developments

Q1

EyePoint Reports First Quarter 2025 Financial Results and Highlights Recent Corporate Developments

2024

Q4

EyePoint Reports Fourth Quarter and Full-Year 2024 Financial Results and Highlights Recent Corporate Developments

Q3

EyePoint Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Corporate Developments

Q2

EyePoint Pharmaceuticals Reports Second Quarter 2024 Financial Results and Highlights Recent Corporate Developments

Q1

EyePoint Pharmaceuticals Reports First Quarter 2024 Financial Results and Highlights Recent Corporate Developments

2023

Q4

EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Corporate Developments 55.4 KB

Q3

EyePoint Pharmaceuticals Reports Third Quarter 2023 Financial Results and Highlights Recent Corporate Developments 70.1 KB

Q2

EyePoint Pharmaceuticals Reports Second Quarter 2023 Financial Results and Highlights Recent Corporate Developments 73 KB

Q1

EyePoint Pharmaceuticals Reports First Quarter 2023 Financial Results and Highlights Recent Corporate Developments 386.7 KB

2022

Q4

EyePoint Pharmaceuticals Reports Fourth Quarter 2022 Financial Results and Highlights Recent Corporate Developments 69.7 KB

Q3

EyePoint Pharmaceuticals Reports Third Quarter 2022 Financial Results and Highlights Recent Corporate Developments 135.7 KB

Q2

EyePoint Pharmaceuticals Reports Second Quarter 2022 Financial Results and Highlights Recent Corporate Developments 139.2 KB

Q1

EyePoint Pharmaceuticals Reports First Quarter 2022 Financial Results and Highlights Recent Corporate Developments 65.6 KB

2021

Q4

EyePoint Pharmaceuticals Reports Fourth Quarter and Full-Year 2021 Financial Results and Highlights Recent Corporate Developments 105 KB

Q3

EyePoint Pharmaceuticals Reports Third Quarter 2021 Financial Results and Highlights Recent Corporate Developments 52.4 KB

Q2

EyePoint Pharmaceuticals Reports Second Quarter 2021 Financial Results and Highlights Recent Corporate Developments 51.1 KB

Q1

EyePoint Pharmaceuticals Reports First Quarter 2021 Financial Results and Highlights Recent Corporate Developments 46.2 KB

2020

Q4

EyePoint Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Corporate Developments 70.2 KB

Q3

EyePoint Pharmaceuticals Reports Third Quarter 2020 Financial Results and Highlights Recent Corporate Developments 77.5 KB

Q2

EyePoint Pharmaceuticals Reports Second Quarter 2020 Financial Results and Highlights Recent Corporate Developments 83.9 KB

Q1

EyePoint Pharmaceuticals Reports First Quarter 2020 Financial Results and Highlights Recent Corporate Developments 69.5 KB

2019

Q4

EyePoint Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results and Highlights Recent Corporate Progress 82.8 KB

Q3

EyePoint Pharmaceuticals Reports Third Quarter 2019 Financial Results and Highlights Recent Corporate Progress 82.4 KB

Q2

EyePoint Pharmaceuticals Reports Second Quarter 2019 Financial Results and Highlights Recent Company Progress 85.9 KB

Q1

EyePoint Pharmaceuticals Reports First Quarter 2019 Financial Results and Highlights Recent Company Progress 83.8 KB

2018

Q4

EyePoint Pharmaceuticals Reports Fiscal 2018 Fourth Quarter & Full Year Financial Results and Highlights Recent Progress 87.5 KB

Q3

EyePoint Pharmaceuticals Reports Fiscal Third Quarter 2018 Results 53.1 KB

Q2

pSivida Corp. Reports Second Quarter FY2018 Results; Continues to Achieve Milestones and Timelines 46.8 KB

Q1

pSivida Corp. Builds Momentum During First Quarter FY18; Continues Operating Milestone Execution 37.9 KB

2017

Q4

pSivida Corp. Achieves Significant Milestones Throughout FY 2017; Reports Fourth Quarter and Fiscal 2017 Results 46.8 KB

Q3

pSivida Corp. Reports Fiscal 2017 Third Quarter Results; Key Milestones on Track 53 KB

Q2

pSivida Corp. Reports Fiscal 2017 Second Quarter and First Half Results 48 KB

Q1

pSivida Corp. Reports Fiscal 2017 First Quarter Results and Provides Update on Corporate Objectives & Milestone Timeline 44.8 KB

480 Pleasant Street, Suite C-400
Watertown, MA 02472

600 Commerce Park Drive
Northbridge, MA 01534

1-833-EYEPOINT (1.833.393.7646)

Science & Technology
Our Programs
About Us
Working At Eyepoint
Investors

News & Resources
Contact

Terms and Conditions
Privacy Policy
Cookies Notice
Compliance

Terms and Conditions
Privacy Policy
Cookies Notice
Compliance

© 2026 EyePoint, Inc. All Rights Reserved

DURASERT®, DURASERT E™, DURAVYU™, EyePoint®, and the EyePoint Logo® are trademarks of EyePoint or its subsidiary.